Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Intellectual Disability

1-methyl-3-isobutylxanthine has been researched along with Intellectual Disability in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berry-Kravis, E1
Huttenlocher, PR1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Intellectual Disability

ArticleYear
Cyclic AMP metabolism in fragile X syndrome.
    Annals of neurology, 1992, Volume: 31, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Adolescent; Adult; Alprostadil; Blood Platelets; Child; Child, Preschoo

1992